Skip to main content
aap Implantate AG logo

aap Implantate AG — Investor Relations & Filings

Ticker · AAQ1 ISIN · DE000A3H2101 LEI · 39120001TRQTQ01LPP57 F Manufacturing
Filings indexed 854 across all filing types
Latest filing 2024-10-22 Share Issue/Capital Cha…
Country DE Germany
Listing F AAQ1

About aap Implantate AG

https://www.aap.de/

aap Implantate AG is a medical technology company that operates as a pure player in the field of traumatology. The company develops, manufactures, and markets implants for the treatment of bone fractures. Its core product is the LOQTEQ® system, a comprehensive portfolio of anatomical plates and screws featuring a patented technology that combines fracture compression with angle-stable locking. This titanium-based system is designed to cover a broad spectrum of indications in upper and lower extremity trauma surgery. In addition to its established product line, aap is developing next-generation platform technologies, including antibacterial silver-coated implants to reduce infection risk and resorbable magnesium implants intended to eliminate the need for secondary removal surgeries.

Recent filings

Filing Released Lang Actions
aap Implantate AG: Cash capital increase and intended non-cash capital increase
Share Issue/Capital Change Classification · 98% confidence The document is an 'Ad-hoc' announcement dated October 22, 2024, disclosing a 'Cash capital increase and intended non-cash capital increase' by aap Implantate AG. This action involves issuing new shares to raise capital and strengthen the equity base, which directly relates to the company's financing activities and capital structure. This aligns perfectly with the definition for 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a dividend notice (DIV).
2024-10-22 English
aap Implantate AG: Step-by-step restart of IT systems
Legal Proceedings Report Classification · 99% confidence The document is an 'Ad-hoc' release dated October 18, 2024, disclosing information under Article 17 of MAR (Regulation (EU) No 596/2014) regarding a step-by-step restart of IT systems following a suspected cyberattack. This type of immediate, material, non-scheduled disclosure concerning operational status and potential data security issues does not fit neatly into the specific categories like 10-K, ER, or IR. It is a general regulatory announcement concerning a material event that is not covered by other specific codes (like DIRS, DIV, or CAP). Therefore, the most appropriate fallback category is Regulatory Filings (RNS), as it serves as the general category for miscellaneous regulatory announcements.
2024-10-18 English
aap Implantate AG: Possible cyber attack on aap
Regulatory Filings Classification · 95% confidence The document is an 'Ad-hoc' announcement dated 15 October 2024, disclosing 'Inside Information' according to Article 17 MAR (Market Abuse Regulation). The content describes a potential cyber attack on the company's IT systems. This type of urgent, material, non-scheduled disclosure regarding a significant operational event (cyber attack) that is not a standard financial report (like 10-K, ER, or IR) or a specific corporate action (like DIV, SHA, DIRS) fits best under the general category for regulatory announcements that do not fit elsewhere, which is 'Regulatory Filings' (RNS). It is not a transcript (CT), an earnings release (ER), or a management discussion (MDA).
2024-10-15 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Voting Rights Announcements' and explicitly states 'Veröffentlichung einer Stimmrechtsmitteilung' (Publication of a voting rights notification). It details changes in share ownership percentages (e.g., 25.74%) and references German securities law (§ 40 Abs. 1 WpHG). This directly corresponds to the definition of Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official results from shareholder votes and related notifications, although the primary focus here is the change in voting rights notification. Reviewing the definitions, 'Declaration of Voting Results & Voting Rights Announcements (Code: DVA)' is the most precise fit for a 'Stimmrechtsmitteilung' (Voting Rights Notification) regarding changes in share ownership thresholds.
2024-10-09 German
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Stimmrechtsmitteilung' (Voting Rights Notification) and explicitly mentions 'Veröffentlichung einer Stimmrechtsmitteilung' (Publication of a voting rights notification) under German WpHG regulations (§ 40 Abs. 1 WpHG). It details changes in share ownership percentages and the total number of voting rights. This directly corresponds to the definition of a notification regarding changes in significant share ownership levels, which aligns best with the 'Major Shareholding Notification' category (MRQ). Although it is a regulatory filing, MRQ is more specific than the general RNS fallback.
2024-10-09 German
Progress in the MDR process - important MDR initial certification audit carried out
Regulatory Filings Classification · 100% confidence The document is a short news release dated October 7, 2024, disseminated via EQS-News. The content reports on a specific operational milestone: the successful completion of an initial certification audit for the MDR (Medical Device Regulation) process. It is not a full financial report (like 10-K or IR), an earnings release (ER), or a presentation (IP). It is an announcement concerning regulatory compliance progress. Since it is a specific, non-financial regulatory update that doesn't fit into categories like Director's Dealing (DIRS), Capital Change (CAP), or Dividend (DIV), it falls best under the general 'Regulatory Filings' (RNS) category, which serves as a fallback for miscellaneous regulatory announcements not covered by more specific codes. Given its brevity and nature as an update on a regulatory process, RNS is the most appropriate classification.
2024-10-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.